Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2.15M Buy
28,567
+680
+2% +$54.1K ﹤0.01% 1807
2023
Q4
$2.05M Buy
27,887
+3,372
+14% +$209K ﹤0.01% 1863
2023
Q3
$1.13M Sell
24,515
-3,222
-12% -$143K ﹤0.01% 2229
2023
Q2
$1.17M Buy
27,737
+4,121
+17% +$156K ﹤0.01% 2279
2023
Q1
$616K Buy
23,616
+5,229
+28% +$155K ﹤0.01% 2633
2022
Q4
$548K Buy
18,387
+10,793
+142% +$301K ﹤0.01% 2726
2022
Q3
$148K Buy
7,594
+7,576
+42,089% +$127K ﹤0.01% 3337
2022
Q2
$0 Buy
+18
New +$190 ﹤0.01% 4183

Other funds holding NUVL

Credit Suisse's NUVL Position: Q1 2024 in Review

Credit Suisse increased its Nuvalent (NUVL) stake by 2.4% in Q1 2024, buying an estimated $54.1K and bringing the position to 28,567 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1807.

Credit Suisse first reported a position in NUVL in Q2 2022 and has held it in 8 quarters since. 180 funds tracked by Wall St. Rank hold NUVL as of Q1 2024.

  • Credit Suisse held 28,567 shares of Nuvalent worth $2.15M as of Q1 2024.
  • Credit Suisse bought 680 Nuvalent shares in Q1 2024, an estimated $54.1K.
  • Nuvalent made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1807 holding.
  • Credit Suisse first reported a position in Nuvalent in Q2 2022 and has held it in 8 quarters since.
  • 180 funds tracked by Wall St. Rank held Nuvalent as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.